Published in Am J Nephrol on May 04, 2010
Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol (2012) 2.97
Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int (2011) 2.94
Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr (2011) 2.01
Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci (2012) 1.12
Clinical review: Biomarkers of acute kidney injury: where are we now? Crit Care (2012) 1.12
Lipocalin 2 expression is associated with aggressive features of endometrial cancer. BMC Cancer (2012) 0.92
The role of urinary liver-type fatty acid-binding protein in critically ill patients. J Korean Med Sci (2013) 0.83
Urinary biomarkers for early detection of recovery in patients with acute kidney injury. J Korean Med Sci (2013) 0.82
Intra-abdominal hypertension does not predict renal recovery or in-hospital mortality in critically ill patients with acute kidney injury. Kidney Res Clin Pract (2015) 0.81
The different molecular forms of urine neutrophil gelatinase-associated lipocalin present in dogs with urinary diseases. BMC Vet Res (2014) 0.81
The incidence and risk factors of acute kidney injury after hepatobiliary surgery: a prospective observational study. BMC Nephrol (2014) 0.81
New biomarkers for the quick detection of acute kidney injury. ISRN Nephrol (2012) 0.78
The potential use of biomarkers in predicting contrast-induced acute kidney injury. Int J Nephrol Renovasc Dis (2016) 0.77
Clinical utility of urine neutrophil gelatinase-associated lipocalin measured at admission to predict outcomes in heterogeneous population of critically ill patients. Indian J Nephrol (2016) 0.75
Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury. Eur J Pediatr (2017) 0.75
Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant (2006) 2.08
Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. Bioconjug Chem (2003) 1.67
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int (2005) 1.41
Newly developed techniques to study and diagnose acute renal failure. J Am Soc Nephrol (2003) 1.38
Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant (2007) 1.37
Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury. J Am Soc Nephrol (2010) 1.31
The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: a population-based cross-sectional epidemiologic study. J Korean Med Sci (2009) 1.24
Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged mice. Kidney Int (2005) 1.21
Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses. Physiol Genomics (2006) 1.19
Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells. Nephron (2002) 1.14
Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. J Am Soc Nephrol (2006) 1.12
Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. Kidney Int (2002) 1.09
Effect of retinoic acid in experimental diabetic nephropathy. Immunol Cell Biol (2004) 1.08
Depletion of kidney CD11c+ F4/80+ cells impairs the recovery process in ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant (2010) 1.05
Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med (2012) 1.05
IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells. J Am Soc Nephrol (2013) 1.01
Reduction of renal fibrosis as a result of liposome encapsulated clodronate induced macrophage depletion after unilateral ureteral obstruction in rats. Nephron Exp Nephrol (2006) 0.99
Heat preconditioning attenuates renal injury in ischemic ARF in rats: role of heat-shock protein 70 on NF-kappaB-mediated inflammation and on tubular cell injury. J Am Soc Nephrol (2006) 0.99
Low iPTH can predict vascular and coronary calcifications in patients undergoing peritoneal dialysis. Nephron Clin Pract (2010) 0.99
The mildly elevated serum bilirubin level is negatively associated with the incidence of end stage renal disease in patients with IgA nephropathy. J Korean Med Sci (2009) 0.97
Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure. J Magn Reson Imaging (2004) 0.97
The role of Tregs and CD11c(+) macrophages/dendritic cells in ischemic preconditioning of the kidney. Kidney Int (2010) 0.95
NecroX-5 prevents hypoxia/reoxygenation injury by inhibiting the mitochondrial calcium uniporter. Cardiovasc Res (2012) 0.94
Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based magnetic resonance contrast agent. Kidney Int (2002) 0.94
Carpal tunnel syndrome and peripheral polyneuropathy in patients with end stage kidney disease. J Korean Med Sci (2011) 0.93
Mitochondrial peroxiredoxin III is a potential target for cancer therapy. Int J Mol Sci (2011) 0.90
CD4+ CD25+ regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant (2010) 0.88
The effect of alpha-melanocyte-stimulating hormone on renal tubular cell apoptosis and tubulointerstitial fibrosis in cyclosporine A nephrotoxicity. Transplantation (2004) 0.87
Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. Diabetologia (2014) 0.87
A case of multiple organ failure due to heat stoke following a warm bath. Korean J Intern Med (2006) 0.86
Glucocorticoids and their receptors: insights into specific roles in mitochondria. Prog Biophys Mol Biol (2013) 0.86
Glucocorticoids attenuate septic acute kidney injury. Biochem Biophys Res Commun (2013) 0.86
Micro-MRI methods to detect renal cysts in mice. Kidney Int (2004) 0.86
Role of inflammation in the pathogenesis of cardiorenal syndrome in a rat myocardial infarction model. Nephrol Dial Transplant (2013) 0.85
Urinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study. BMC Nephrol (2012) 0.84
Association between depression symptoms with inflammation and cardiovascular risk factors in patients undergoing peritoneal dialysis. Nephron Clin Pract (2010) 0.84
Sphingosine-1-phosphate reduces hepatic ischaemia/reperfusion-induced acute kidney injury through attenuation of endothelial injury in mice. Nephrology (Carlton) (2011) 0.83
The role of urinary liver-type fatty acid-binding protein in critically ill patients. J Korean Med Sci (2013) 0.83
Hemophagocytic syndrome in a patient with acute tubulointerstitial nephritis secondary to hepatitis A virus infection. J Korean Med Sci (2010) 0.82
The use of everolimus to target carcinogenic pathways in a patient with renal cell carcinoma and tuberous sclerosis complex: a case report. J Med Case Rep (2014) 0.82
Insomnia in diabetic hemodialysis patients. Prevalence and risk factors by a multicenter study. Nephron (2002) 0.81
The incidence and risk factors of acute kidney injury after hepatobiliary surgery: a prospective observational study. BMC Nephrol (2014) 0.81
IL-10 mediates rosiglitazone-induced kidney protection in cisplatin nephrotoxicity. J Korean Med Sci (2010) 0.81
Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response. Transpl Immunol (2011) 0.81
Association of complement 5 genetic polymorphism with renal allograft outcomes in Korea. Nephrol Dial Transplant (2011) 0.80
Primed monocytes: putative culprits of chronic low-grade inflammation and impaired innate immune responses in patients on hemodialysis. Clin Exp Nephrol (2010) 0.79
Soluble CD25 is increased in patients with sepsis-induced acute kidney injury. Nephrology (Carlton) (2014) 0.79
Roles of Toll-like receptors in allogeneic islet transplantation. Transplantation (2012) 0.79
Interleukin-10 and tumor necrosis factor-alpha polymorphisms in vascular access failure in patients on hemodialysis: preliminary data in Korea. J Korean Med Sci (2008) 0.78
Altered monocyte-derived dendritic cell function in patients on hemodialysis: a culprit for underlying impaired immune responses. Clin Exp Nephrol (2011) 0.78
Microinflammation in hemodialysis patients is associated with increased CD14CD16(+) pro-inflammatory monocytes: possible modification by on-line hemodiafiltration. Blood Purif (2011) 0.78
CD11c⁺ cells partially mediate the renoprotective effect induced by bone marrow-derived mesenchymal stem cells. PLoS One (2013) 0.78
Desquamative interstitial pneumonia associated with concurrent cytomegalovirus and Aspergillus pneumonia in a renal transplant recipient. Nephrol Dial Transplant (2005) 0.78
Effect of IgA aggregates on transforming growth factor-beta1 production in human mesangial cells and the intraglomerular expression of transforming growth factor-beta1 in patients with IgA nephropathy. Korean J Intern Med (2005) 0.77
Postoperative hemolytic uremic syndrome with renal cortical necrosis following laparoscopic hemicolectomy. Ren Fail (2013) 0.77
Roles of islet Toll-like receptors in pig to mouse islet xenotransplantation. Cell Transplant (2012) 0.77
Kidney transplantation after desensitization in sensitized patients: a Korean National Audit. Int Urol Nephrol (2012) 0.77
Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation. Medicine (Baltimore) (2016) 0.76
A single-center experience of overseas kidney transplant for immunologically high-risk patients. Exp Clin Transplant (2015) 0.75